Kodiak Sciences Net Worth

Kodiak Sciences Net Worth Breakdown

  KOD
The net worth of Kodiak Sciences is the difference between its total assets and liabilities. Kodiak Sciences' net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Kodiak Sciences' assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Kodiak Sciences' net worth can be used as a measure of its financial health and stability which can help investors to decide if Kodiak Sciences is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Kodiak Sciences stock.

Kodiak Sciences Net Worth Analysis

Kodiak Sciences' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Kodiak Sciences' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Kodiak Sciences' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Kodiak Sciences' net worth analysis. One common approach is to calculate Kodiak Sciences' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Kodiak Sciences' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Kodiak Sciences' net worth. This approach calculates the present value of Kodiak Sciences' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Kodiak Sciences' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Kodiak Sciences' net worth. This involves comparing Kodiak Sciences' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Kodiak Sciences' net worth relative to its peers.

Enterprise Value

232.05 Million

To determine if Kodiak Sciences is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Kodiak Sciences' net worth research are outlined below:
Kodiak Sciences appears to be risky and price may revert if volatility continues
Kodiak is showing solid risk-adjusted performance over 90 days
Reported Net Loss for the year was (260.49 M) with profit before taxes, overhead, and interest of 0.
Kodiak Sciences has about 597.88 M in cash with (154.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 11.55, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Over 78.0% of the company shares are owned by institutional investors
Latest headline from zacks.com: Kodiak Sciences Inc. Just Flashed Golden Cross Signal Do You Buy
Kodiak Sciences uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Kodiak Sciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Kodiak Sciences' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
26th of March 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Know Kodiak Sciences' Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Kodiak Sciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Kodiak Sciences backward and forwards among themselves. Kodiak Sciences' institutional investor refers to the entity that pools money to purchase Kodiak Sciences' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Jacobs Levy Equity Management, Inc.2024-09-30
580.8 K
Silverarc Capital Management, Llc2024-09-30
500 K
Dimensional Fund Advisors, Inc.2024-09-30
495.2 K
Hudson Bay Capital Management Lp2024-09-30
493.5 K
Ikarian Capital, Llc2024-09-30
476.6 K
Bruce & Co Inc2024-09-30
423 K
Morgan Stanley - Brokerage Accounts2024-09-30
361.2 K
Two Sigma Advisers, Llc2024-09-30
333.3 K
Goldman Sachs Group Inc2024-09-30
318.8 K
Baker Bros Advisors Lp2024-09-30
17.3 M
Blackrock Inc2024-06-30
3.8 M
Note, although Kodiak Sciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Kodiak Sciences' market capitalization trends

The company currently falls under 'Small-Cap' category with a total capitalization of 351 M.

Market Cap

319.86 Million

Project Kodiak Sciences' profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.54)(0.57)
Return On Capital Employed(0.63)(0.60)
Return On Assets(0.54)(0.57)
Return On Equity(0.98)(0.93)
When accessing Kodiak Sciences' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Kodiak Sciences' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Kodiak Sciences' profitability and make more informed investment decisions.
Please note, the presentation of Kodiak Sciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Kodiak Sciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Kodiak Sciences' management manipulating its earnings.

Evaluate Kodiak Sciences' management efficiency

Kodiak Sciences has Return on Asset of (0.2672) % which means that on every $100 spent on assets, it lost $0.2672. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.715) %, meaning that it generated no profit with money invested by stockholders. Kodiak Sciences' management efficiency ratios could be used to measure how well Kodiak Sciences manages its routine affairs as well as how well it operates its assets and liabilities. As of December 2, 2024, Return On Tangible Assets is expected to decline to -0.57. The current year's Return On Capital Employed is expected to grow to -0.6. At present, Kodiak Sciences' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 78.3 M, whereas Non Currrent Assets Other are forecasted to decline to about 8.3 M.
Last ReportedProjected for Next Year
Book Value Per Share 5.07  5.58 
Tangible Book Value Per Share 5.07  5.58 
Enterprise Value Over EBITDA 0.17  0.18 
Price Book Value Ratio 0.60  0.63 
Enterprise Value Multiple 0.17  0.18 
Price Fair Value 0.60  0.63 
Enterprise Value244.3 M232.1 M
The management team at Kodiak Sciences has a track record of steering the company towards sustained growth. Evaluating their strategies helps in understanding the stock's long-term potential.
Return On Equity
(0.71)
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Kodiak Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Kodiak Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Kodiak Sciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Baker Bros. Advisors Lp over a month ago
Acquisition by Baker Bros. Advisors Lp of 90674 shares of Kodiak Sciences at 5.9877 subject to Rule 16b-3
 
Perlroth Victor over three months ago
Acquisition by Perlroth Victor of 406000 shares of Kodiak Sciences at 2.49 subject to Rule 16b-3
 
Ehrlich Jason over three months ago
Disposition of 1205 shares by Ehrlich Jason of Kodiak Sciences at 7.21 subject to Rule 16b-3
 
Bancroft Charles A over three months ago
Acquisition by Bancroft Charles A of 40000 shares of Kodiak Sciences at 2.35 subject to Rule 16b-3
 
Borgeson John A. over three months ago
Disposition of 2874 shares by Borgeson John A. of Kodiak Sciences at 2.75 subject to Rule 16b-3
 
Borgeson John A. over three months ago
Disposition of 1558 shares by Borgeson John A. of Kodiak Sciences at 2.92 subject to Rule 16b-3
 
Borgeson John A. over three months ago
Disposition of 3025 shares by Borgeson John A. of Kodiak Sciences subject to Rule 16b-3
 
Dahiyat Bassil I over six months ago
Acquisition by Dahiyat Bassil I of 25000 shares of Kodiak Sciences subject to Rule 16b-3
 
Baker Bros. Advisors Lp over six months ago
Acquisition by Baker Bros. Advisors Lp of 11945 shares of Kodiak Sciences at 7.7488 subject to Rule 16b-3
 
Jason Ehrlich over six months ago
Disposition of 1205 shares by Jason Ehrlich of Kodiak Sciences at 7.21 subject to Rule 16b-3
 
Richard Levy over a year ago
Acquisition by Richard Levy of 40000 shares of Kodiak Sciences subject to Rule 16b-3
 
Jason Ehrlich over a year ago
Acquisition by Jason Ehrlich of 207500 shares of Kodiak Sciences subject to Rule 16b-3

Kodiak Sciences Corporate Filings

8K
14th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
7th of August 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
23rd of April 2024
Other Reports
ViewVerify
13A
14th of February 2024
An amended filing to the original Schedule 13G
ViewVerify
Kodiak Sciences time-series forecasting models is one of many Kodiak Sciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Kodiak Sciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Kodiak Sciences Earnings per Share Projection vs Actual

Kodiak Sciences Corporate Management

Tracy ChienVP ControllerProfile
Almas MScSenior OperationsProfile
Victor MDChairman, CoFounderProfile
Michael LouieSenior OfficerProfile
CPA MBACFO VPProfile
Pablo MDSenior DevelopmentProfile
Stephen RaillardSenior ManufacturingProfile
When determining whether Kodiak Sciences is a strong investment it is important to analyze Kodiak Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Kodiak Sciences' future performance. For an informed investment choice regarding Kodiak Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kodiak Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For information on how to trade Kodiak Stock refer to our How to Trade Kodiak Stock guide.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kodiak Sciences. If investors know Kodiak will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kodiak Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.64)
Return On Assets
(0.27)
Return On Equity
(0.71)
The market value of Kodiak Sciences is measured differently than its book value, which is the value of Kodiak that is recorded on the company's balance sheet. Investors also form their own opinion of Kodiak Sciences' value that differs from its market value or its book value, called intrinsic value, which is Kodiak Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kodiak Sciences' market value can be influenced by many factors that don't directly affect Kodiak Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kodiak Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kodiak Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kodiak Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.